Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction.
By J. Rasmussen, A. Chong, D. Alter. Journal of the American Medical Association (JAMA), 2007
1,007 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Family Practice
View Paper: https://www.semanticscholar.org/paper/6ed46a5b9503c5c685bf3c6f292bc7c3e4370491
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- We need minimally disruptive medicine (2009, background): “Poor adherence to medical advice and drug regimens is a global problem with a long history. Non-adherence is important because many therapeutic interventions are effective only if used correctly, which requires continuous personal investment of time and effort from patients. The epidemiological tran”
- ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). (2011, background): “care; such programmes are also more appropriate for initiating and up-titrating drug therapies, achieving the treatment goals, and adherence over the long-term which in turn improves eventfree survival.(220) However, in everyday care, statins are usually prescribed at the lowest dose and often not u”
- Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. (2012, background): “Access, self-care, and unmet need are all associated with health, quality of life, and mortality [7,124e127]; particularly direct examples include highly active antiretroviral therapy [128e132] and postmyocardial infarction care [133,134].”
- Self-report measures of medication adherence behavior: recommendations on optimal use (2015, background): “Acrossmany chronicmedical conditions, adherence has been associated with positive clinical outcomes including improved disease control, reduced symptoms, and decreased complications, hospitalization, and mortality [13–20].”
- EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries (2016, background): “The last is associated with higher cardiovascular event rates, all-cause mortality, and increased health care costs.(29,30) A meta-analysis of observational studies demonstrated that good adherence to drug therapy is associated with positive health outcomes.”